Exaggerated stress-induced release of nonesterified fatty acids in JCR:LA-corpulent rats

Metabolism: Clinical and Experimental

Volumn 47, Issue 11, 1998, Pages 1383-1390

  McArthur, M Dawn ^a   Graham, Sandra E ^a   Russell, James C ^a   Brindley, David N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CORTICOSTERONE; FATTY ACID; GLUCOSE; INSULIN; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CORTICOSTERONE RELEASE; FATTY ACID BLOOD LEVEL; FATTY ACID TRANSPORT; GENOTYPE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPOLYSIS; MALE; NONHUMAN; NORADRENALIN RELEASE; OBESITY; PRIORITY JOURNAL; RAT; STRESS;

EID: 0031756839     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90310-9     Document Type: Article

References (40)

1. Pacak K, Palkovits M, Kopin IJ, et al: Stress-induced norepinephrine release in the hypothalamic-paraventricular nucleus and pituitaryadrenocortical and sympathoadrenal activity: In vivo microdialysis studies. Front Neuroendocrinol 16:89-150, 1995
2. Pare WP, Glavin GB: Restraint stress in biomedical research: A review. Neurosci Behav Rev 10:338-370, 1986
3. Bray GA, Fisler J, York DA: Neuroendocrine control of the development of obesity: Understanding gained from studies of experimental animal models. Front Neuroendocrinol 11:128-181, 1990
4. Brindley DN: Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int J Obes 19:S69-S75, 1995 (suppl 1)
5. Pacak K, McCarty R, Palkovits M, et al: Decreased central and peripheral catecholaminergic activation in obese Zucker rats. Endocrinology 136:4360-4367, 1995
6. Levin BE, Comai K, Sullivan AC: Metabolic and sympathoadrenal abnormalities in the obese Zucker rat: Effect of chronic phenoxybenzamine treatment. Pharmacol Biochem Behav 14:517-525, 1991
7. Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeanrenaud B: Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats. Diabetologia 36:899-906, 1993
8. Bjorntorp P: Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143, 1991
9. 3-adrenoceptors in obesity. J Clin Invest 95:1109-1116, 1995
10. Al-Sieni AII, Plested CP, Rolland Y, et al: Decreased incorporation of glucose into lipids and increased lactate production by adipose tissue after long-term treatment of rats with D-fenfluramine. Biochem Pharmacol 38:3661-3667, 1989
11. Russell JC: The atherosclerosis-prone JCR:LA-corpulent rat, in Woodford FP, Davignon J, Sniderman A (eds): Atherosclerosis X. New York, NY, Elsevier, 1995, pp 121-125
12. Amy RM, Dolphin PJ, Pederson RA, et al: Atherogenesis in two strains of obese rats, the fatty Zucker and LA/N-corpulent. Atherosclerosis 69:199-209, 1988
13. Brindley DN, McCann BS, Niaura R, et al: Stress and lipoprotein metabolism: Modulators and mechanisms. Metabolism 42:1-13, 1993 (suppl 1)
14. DeFronzo RA, Ferrannini E: Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
15. Reaven GM, Chen YI: Role of abnormal fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus. Am J Med 85:106-112, 1988 (suppl 5A)
16. Kvetnansky R, Goldstein DS, Weise VK, et al: Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines and metabolites in rats. J Neurochem 58:2296-2302, 1992
17. Shillabeer G, Forden JM, Russell JC, et al: Paradoxically slow preadipocyte replication and differentiation in corpulent rats. Am J Physiol 258:E368-E376, 1990 (suppl)
18. Wieland O: Glycerol UV method, in Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York, NY, Academic, 1972, pp 1404-1414
19. Bouchard C, Després J-P, Mauriege P: Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 14:72-93, 1993
20. Zucker I: Fat mobilization in vitro and in vivo in the genetically obese Zucker rat "fatty." J Lipid Res 13:234-243, 1972
21. Bray GA, Mothon S, Cohen AS: Mobilization of fatty acids in genetically obese rats. J Lipid Res 11:517-521, 1970
22. Levin BE, Triscari J, Sullivan AC: Studies of origins of abnormal sympathetic function in obese Zucker rats. Am J Physiol 245:E87-E93, 1983 (suppl)
23. Paolisso G, Tataranni PA, Foley JE, et al: A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213-1217, 1995
24. Roden M, Price TB, Perseghin G, et al: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865, 1996
25. Kvetnansky R, McCarty R, Thoa NB, et al: Sympathoadrenal responses of spontaneously hypertensive rats to immobilization stress. Am J Physiol 236:H457-H462, 1979 (suppl)
26. Lee TF, Wang LCH, Russell JC: Enhancement of cold-stimulated thermogenesis in the corpulent rat (LA/N-cp) by aminophylline. Am J Physiol 252:R737-R742, 1987 (suppl)
27. Marette A, Mauriege P, Després J-P, et al: Norepinephrine- and insulin-resistant glucose transport in brown adipocytes from diabetic SHR/N-cp rats. Am J Physiol 265:R577-R583, 1993 (suppl)
28. Tannenbaum BM, Brindley DN, Tannenbaum GS, et al: High-fat feeding alters both basal and stress-induced hypothalamic-pituitaryadrenal activity in the rat. Am J Physiol 273:E1168-E1177, 1997 (suppl)
29. Malchoff CD, Pohl SL, Kaiser DL, et al: Determinants of glucose and ketoacid concentrations in acutely hyperglycemic diabetic patients. Am J Med 77:275-285, 1984
30. Lee Y, Hirose H, Ohneda M, et al: β-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-β-cell relationships. Proc Natl Acad Sci USA 91:10878-10882, 1994
31. McGarry JD: Disordered metabolism in diabetes: Have we underemphasized the fat component? J Cell Biochem 558:29-38, 1994 (suppl)
32. Randle PJ, Priestman DA, Mistry SC, et al: Glucose fatty acid interactions and the regulation of glucose disposal. J Cell Biochem 558:1-11, 1994 (suppl)
33. Swislocki ALM, Chen YDI, Golay A, et al: Insulin suppression of plasma free fatty acid concentrations in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 30:622-626, 1987
34. Svedberg J, Stromblad G, Wirth A, et al: Fatty acids in the portal vein of the rat regulate hepatic insulin clearance. J Clin Invest 88:2054-2058, 1991
35. Boden G, Chen X, Ruiz J, et al: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
36. Svedberg J, Bjorntorp P, Smith U, et al: Effect of free fatty acids on insulin receptor binding and tyrosine kinase activity in hepatocytes isolated from lean and obese rats. Diabetes 41:294-298, 1992
37. Kim JK, Wi JK, Youn JH: Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes 45:446-452, 1996
38. Hunnicutt JW, Hardy RW, Williford J, et al: Saturated fatty acid-induced insulin resistance in rat adipocytes. Diabetes 43:540-545, 1994
39. Stein DT, Esser V, Stevenson BE, et al: Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728-2735, 1996
40. Zhou YP, Grill VE: Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876, 1994